Patents by Inventor Paula Dakin

Paula Dakin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for safe and effective treatment of knee and/or hip pain
    Patent number: 11472870
    Abstract: A pharmaceutical composition and a method for treating knee and/or hip pain in a patient non-responsive or intolerant to standard analgesic therapy are disclosed. A pharmaceutical composition and a method for reducing risk for developing an arthropathy in a subject receiving an anti-NGF antibody for treatment of knee and/or hip pain are disclosed. Also provided herein are methods for monitoring safety of a treatment of knee and/or hip pain involving administration of an anti-NGF antibody. In certain aspects, the subject has osteoarthritis of the knee and/or hip and the anti-NGF antibody is fasinumab.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: October 18, 2022
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Gregory Geba, Paula Dakin, Stephen DiMartino, Haitao Gao, Sr., Jennifer Maloney, John Davis, Catherine Stehman Breen
  • Pharmaceutical Composition for Safe and Effective Treatment of Knee and/or Hip Pain
    Publication number: 20220041708
    Abstract: A pharmaceutical composition and a method for treating knee and/or hip pain in a patient non-responsive or intolerant to standard analgesic therapy are disclosed. A pharmaceutical composition and a method for reducing risk for developing an arthropathy in a subject receiving an anti-NGF antibody for treatment of knee and/or hip pain are disclosed. Also provided herein are methods for monitoring safety of a treatment of knee and/or hip pain involving administration of an anti-NGF antibody. In certain aspects, the subject has osteoarthritis of the knee and/or hip and the anti-NGF antibody is fasinumab.
    Type: Application
    Filed: October 26, 2021
    Publication date: February 10, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Gregory GEBA, Paula DAKIN, Stephen DIMARTINO, Haitao GAO, Jennifer MALONEY, John DAVIS, Catherine Stehman BREEN
  • PHARMACEUTICAL COMPOSITION FOR SAFE AND EFFECTIVE TREATMENT OF KNEE AND/OR HIP PAIN
    Publication number: 20200048337
    Abstract: A pharmaceutical composition and a method for treating knee and/or hip pain in a patient non-responsive or intolerant to standard analgesic therapy are disclosed. A pharmaceutical composition and a method for reducing risk for developing an arthropathy in a subject receiving an anti-NGF antibody for treatment of knee and/or hip pain are disclosed. Also provided herein are methods for monitoring safety of a treatment of knee and/or hip pain involving administration of an anti-NGF antibody. In certain aspects, the subject has osteoarthritis of the knee and/or hip and the anti-NGF antibody is fasinumab.
    Type: Application
    Filed: August 9, 2019
    Publication date: February 13, 2020
    Applicant: REGENERON PHARMACEUTICALS, INC.
    Inventors: Gregory Geba, Paula Dakin, Stephen DiMartino, Haltao Gao, Sr., Jennifer Maloney, John DAVIS, Catherine Stehman BREEN